Could Hemogram Parameters Be Useful Biomarkers for The Diagnosis of Impaired Glucose Tolerance ?
Yıl: 2022 Cilt: 14 Sayı: 1 Sayfa Aralığı: 9 - 12 Metin Dili: İngilizce DOI: 10.18521/ktd.843666 İndeks Tarihi: 29-07-2022
Could Hemogram Parameters Be Useful Biomarkers for The Diagnosis of Impaired Glucose Tolerance ?
Öz: Objective: Elevated blood glucose may be affect complete blood count parameters. In this study, we compared the hemogram parameters of healthy individuals and cases with impaired glucose tolerance.
Method: We examineted 134 patients with impaired glucose tolerance and 30 healthy cases. Patients files were evaluated retrospectively and the levels of hemoglobin, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin, red blood cell, red cell distribution wide, mean platelet volume, platelet distribution wide, leukocycte, neutrophil, lymphocycte, platelet, and hemoglobin A1c were recorded. Control and patient groups were compared in terms of these parameters with student T test. In addition, the relationship between hemoglobin A1c value and complete blood count parameters were determined in patients with impaired glucose tolerance.
Results: There was no significantly difference between study and control groups in terms of hemoglobin, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin, red blood cell count, red cell distrubition wide, leukocycte, neutrophil, lymphocycte, platelet levels. The mean platelet volume and platelet distribution wide values were significantly higher in the patient group than the control group (p value: 0.002, p value: 0.04 respectively).
Conclusion: Complete blood count is an easy, inexpensive test that can be performed in most hospitals. If our study results are supported by other studies, some hemogram parameters may be used to diagnose of impaired glucose tolerance.
Anahtar Kelime: Bozulmuş Glukoz Toleransının Tanısında Hemogram Parametreleri Biyobelirteç Olarak Kullanılabilir mi?
Öz: Amaç: Yüksek kan şekeri, tam kan sayımı parametrelerini etkileyebilir. Biz bu çalışmada sağlıklı bireylerin ve bozulmuş glukoz toleranslı olguların hemogram parametrelerini karşılaştırdık.
Gereç ve Yöntem: Biz bozulmuş glukoz toleranslı 134 hasta ve 30 sağlıklı bireyi inceledik. Hasta dosyaları retrospektif olarak değerlendirildi ve hemoglobin, hematokrit, ortalama eritrosit hacmi, ortalama eritrosit hemoglobini, kırmızı kan hücresi, eritrosit dağılım genişliği, ortalama trombosit hacmi, trombosit dağılım genişliği, lökosit, nötrofil, lenfosit, trombosit ve hemoglobin A1c düzeyleri kaydedildi . Kontrol ve hasta grupları bu parametreler açısından student T testi ile karşılaştırıldı.
Bulgular: Çalışma ve kontrol grupları arasında hemoglobin, hematokrit, ortalama eritrosit hacmi, ortalama eritrosit hemoglobini, kırmızı kan hücresi sayısı, eritrosit dağılım genişliği, lökosit, nötrofil, lenfosit, trombosit düzeyleri açısından anlamlı fark yoktu. Hasta grubunda ortalama trombosit hacmi ve trombosit dağılım genişliği değerleri kontrol grubuna göre anlamlı olarak yüksekti (sırasıyla p değeri: 0.002, p değeri: 0.04).
Sonuç: Tam kan sayımı, çoğu hastanede yapılabilen kolay ve ucuz bir testtir. Çalışma sonuçlarımız başka çalışmalarla desteklenirse, bozulmuş glukoz toleransını teşhis etmek için bazı hemogram parametreleri kullanılabilir.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007;30(3):753–9.
- 2. Levitan EB, Song Y, Ford ES, Liu S. Is non-diabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med. 2004;164:2147–55.
- 3. DECODE Study Group, on behalf of the European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care. 2003;26:688–96.
- 4. The DECODE Study Group for the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and two hour diagnostic criteria. Arch Intern Med. 2001;161: 397 –405.
- 5. Dimitriadis G, Mitrou P, Lambadiari V, Maratou E, Raptis SA. Insulin effects in muscle and adipose tissue. Diabetes Res Clin Pract. 2011;9:52-9.
- 6. Maellaro E, Leoncini S, Moretti D, Del Bello B, Tanganelli I, De Felice C, et al. Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients. Acta Diabetol. 2013;50(4):48995.
- 7. Zuberi BF, Akhtar N, Afsar S. Comparison of mean platelet volume in patients with diabetes mellitus, impaired fasting glucose and non‐diabetic subjects. Singapore Med J. 2008;49:114–6.
- 8. Hekimsoy Z, Payzin B, Ornek T, Kandoğan G. Mean platelet volume in Type 2 diabetic patients. J Diabetes Complications. 2004;18(3):173-6.
- 9. Irace C, Scarinci F, Scorcia V, Bruzzichessi D, Fiorentino R, Randazzo G, et al. Association among low whole blood viscosity, haematocrit, haemoglobin and diabetic retinopathyin subjects with type 2 diabetes. Br J Ophthalmol. 2011;95(1):94–8.
- 10. Ezenwaka CE, Jones-LeCointe A, Nwagbara E, Seales D, Okali F. Anemia and kidney dysfunction in Caribbean type 2 diabetic patients. Cardiovasc Diabetol. 2008;7:25.
- 11.Chen LK, Ming-Hsien L, Zhi-Jun C, Shinn-Jang H, Chiou ST. Association of insulin resistance and hematologic parameters: study of a middle-aged and elderly Chinese population in Taiwan. Chin Med Assoc. 2006;69(6):248–53.
- 12. Aoki I, Taniyama M, Toyama K, Homori M, Ishikawa K. Stimulatory effect of human insulin on erythroid progenitors (CFU-E and BFU-E) in human CD34+ separated bone marrow cells and the relationship between insulin and erythropoietin. Stem Cells. 1994;12:329-38.
- 13. Ellinger VC, Carlini LT, Moreira RO, Meirelles RM. Relation between insulin resistance and hematological parameters in a Brazilian sample. Arq Bras Endocrinol Metabol. 2006;50(1):114–7.
- 14. Alamri BN, Bahabri A, Aldereihim AA, Alabduljabbar M, Alsubaie MM, Alnaqeb D, et al. Hyperglycemia effect on red blood cells indices. Eur Rev Med Pharmacol Sci. 2019;23(5):2139-50.
- 15. Nada AM. Red cell distribution width in type 2 diabetic patients. Diabetes, Metab Syndr Obes Targets Ther. 2015;8:525–33.
- 16.Cakir L, Aktas G, Enginyurt O, Cakir S. Mean platelet volume increases in type 2 diabetes mellitus independent of HbA1c level. Acta Medica Mediterrane. 2014;30:425.
- 17. Nagareddy PR, Murphy AJ , Stirzaker RA, Hu Y, Yu S, Miller RG, et al. Hyperglycemia Promotes Myelopoiesis and Impairs the Resolution of Atherosclerosis. Cell metabolism. 2013;17(5):695-708.
- 18.Chung FM, Tsai JCR, Chang DM, Shin SJ, Lee YJ. Peripheral total and differential leukocyte count in diabetic nephropathy. Diabetes Care. 2005;28(7):1710–7.
- 19. Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis TH, et al Mean platelet volume in patients with type 2 diabetes mellitus. Platelets. 2004;15:475–8.
- 20.Chen X, Fang L, Lin H, Shen P, Zhang T, Li H, et al. The Relationship between Type 2 Diabetes and Platelet Indicators. Iran J Public Heal. 2017;46:1211–6.
| APA | SİNCAN g, Öztürk İ, SINCAN S, erdem f, Şanibaş A (2022). Could Hemogram Parameters Be Useful Biomarkers for The Diagnosis of Impaired Glucose Tolerance ?. , 9 - 12. 10.18521/ktd.843666 |
| Chicago | SİNCAN gulden,Öztürk İlyas,SINCAN Suat,erdem fuat,Şanibaş Ahmet Veli Could Hemogram Parameters Be Useful Biomarkers for The Diagnosis of Impaired Glucose Tolerance ?. (2022): 9 - 12. 10.18521/ktd.843666 |
| MLA | SİNCAN gulden,Öztürk İlyas,SINCAN Suat,erdem fuat,Şanibaş Ahmet Veli Could Hemogram Parameters Be Useful Biomarkers for The Diagnosis of Impaired Glucose Tolerance ?. , 2022, ss.9 - 12. 10.18521/ktd.843666 |
| AMA | SİNCAN g,Öztürk İ,SINCAN S,erdem f,Şanibaş A Could Hemogram Parameters Be Useful Biomarkers for The Diagnosis of Impaired Glucose Tolerance ?. . 2022; 9 - 12. 10.18521/ktd.843666 |
| Vancouver | SİNCAN g,Öztürk İ,SINCAN S,erdem f,Şanibaş A Could Hemogram Parameters Be Useful Biomarkers for The Diagnosis of Impaired Glucose Tolerance ?. . 2022; 9 - 12. 10.18521/ktd.843666 |
| IEEE | SİNCAN g,Öztürk İ,SINCAN S,erdem f,Şanibaş A "Could Hemogram Parameters Be Useful Biomarkers for The Diagnosis of Impaired Glucose Tolerance ?." , ss.9 - 12, 2022. 10.18521/ktd.843666 |
| ISNAD | SİNCAN, gulden vd. "Could Hemogram Parameters Be Useful Biomarkers for The Diagnosis of Impaired Glucose Tolerance ?". (2022), 9-12. https://doi.org/10.18521/ktd.843666 |
| APA | SİNCAN g, Öztürk İ, SINCAN S, erdem f, Şanibaş A (2022). Could Hemogram Parameters Be Useful Biomarkers for The Diagnosis of Impaired Glucose Tolerance ?. KONURALP TIP DERGİSİ, 14(1), 9 - 12. 10.18521/ktd.843666 |
| Chicago | SİNCAN gulden,Öztürk İlyas,SINCAN Suat,erdem fuat,Şanibaş Ahmet Veli Could Hemogram Parameters Be Useful Biomarkers for The Diagnosis of Impaired Glucose Tolerance ?. KONURALP TIP DERGİSİ 14, no.1 (2022): 9 - 12. 10.18521/ktd.843666 |
| MLA | SİNCAN gulden,Öztürk İlyas,SINCAN Suat,erdem fuat,Şanibaş Ahmet Veli Could Hemogram Parameters Be Useful Biomarkers for The Diagnosis of Impaired Glucose Tolerance ?. KONURALP TIP DERGİSİ, vol.14, no.1, 2022, ss.9 - 12. 10.18521/ktd.843666 |
| AMA | SİNCAN g,Öztürk İ,SINCAN S,erdem f,Şanibaş A Could Hemogram Parameters Be Useful Biomarkers for The Diagnosis of Impaired Glucose Tolerance ?. KONURALP TIP DERGİSİ. 2022; 14(1): 9 - 12. 10.18521/ktd.843666 |
| Vancouver | SİNCAN g,Öztürk İ,SINCAN S,erdem f,Şanibaş A Could Hemogram Parameters Be Useful Biomarkers for The Diagnosis of Impaired Glucose Tolerance ?. KONURALP TIP DERGİSİ. 2022; 14(1): 9 - 12. 10.18521/ktd.843666 |
| IEEE | SİNCAN g,Öztürk İ,SINCAN S,erdem f,Şanibaş A "Could Hemogram Parameters Be Useful Biomarkers for The Diagnosis of Impaired Glucose Tolerance ?." KONURALP TIP DERGİSİ, 14, ss.9 - 12, 2022. 10.18521/ktd.843666 |
| ISNAD | SİNCAN, gulden vd. "Could Hemogram Parameters Be Useful Biomarkers for The Diagnosis of Impaired Glucose Tolerance ?". KONURALP TIP DERGİSİ 14/1 (2022), 9-12. https://doi.org/10.18521/ktd.843666 |
